Supreme Court tosses Bristol Myers' bid to revive $1.2B CAR-T case against Gilead
In the latest setback for Bristol Myers Squibb in a years-long legal tussle with Gilead over a CAR-T patent, the Supreme Court of the United …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
